Yuko Nagamura
Overview
Explore the profile of Yuko Nagamura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyazaki M, Nakabo A, Nagano Y, Nagamura Y, Yanagihara K, Ohki R, et al.
Cancer Lett
. 2022 Nov;
553:215983.
PMID: 36404569
Peritoneal metastasis is one of the most frequent causes of death in several types of advanced cancers; however, the underlying molecular mechanisms remain largely unknown. In this study, we exploited...
2.
Yamaguchi H, Nagamura Y, Miyazaki M
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954414
Gastric cancer (GC) is a major cause of cancer-related death worldwide. Patients with an aggressive subtype of GC, known as diffuse-type gastric carcinoma (DGC), have extremely poor prognoses. DGC is...
3.
Miyamoto S, Nagano Y, Miyazaki M, Nagamura Y, Sasaki K, Kawamura T, et al.
Cancer Lett
. 2021 Nov;
526:335-345.
PMID: 34775002
Diffuse-type gastric carcinoma (DGC) has a poor prognosis due to its rapid diffusive infiltration and frequent peritoneal dissemination. DGC is associated with massive fibrosis caused by aberrant proliferation of cancer-associated...
4.
Nagamura Y, Miyazaki M, Nagano Y, Tomiyama A, Ohki R, Yanagihara K, et al.
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503119
Diffuse-type gastric carcinoma (DGC) exhibits aggressive progression associated with rapid infiltrative growth, massive fibrosis, and peritoneal dissemination. Gene amplification of Met and fibroblast growth factor receptor 2 (FGFR2) receptor tyrosine...
5.
Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, et al.
Oncogenesis
. 2021 Mar;
10(3):25.
PMID: 33677467
Met gene amplification has been found in a subset of malignant carcinomas, including diffuse-type gastric carcinoma (DGC), which has a poor prognosis owing to rapid infiltrative invasion and frequent peritoneal...
6.
Miyamoto S, Nagamura Y, Nakabo A, Okabe A, Yanagihara K, Fukami K, et al.
Biochem Biophys Res Commun
. 2017 Dec;
495(2):1942-1947.
PMID: 29247652
RhoA is a member of Rho family small GTPases that regulates diverse cellular functions. Recent large-scale sequencing studies have identified recurrent somatic mutations of RHOA in diffuse-type gastric carcinoma (DGC),...
7.
Yamaguchi H, Ito Y, Miura N, Nagamura Y, Nakabo A, Fukami K, et al.
Eur J Cell Biol
. 2017 Aug;
96(7):685-694.
PMID: 28797528
Invadopodia are ventral membrane protrusions formed by cancer cells that degrade the extracellular matrix (ECM) during tumor invasion and metastasis. Formation of invadopodia is initiated by the assembly of actin...
8.
Nagamura Y, Terawaki K, Uezono Y, Tsukada T
BMC Complement Altern Med
. 2014 Jul;
14:256.
PMID: 25038801
Background: Rikkunshito is a traditional Japanese herbal medicine that is used to treat appetite loss associated with cancer and other disorders. The formulation contains various constituents that influence cell signaling,...
9.
Nagamura Y, Yamazaki M, Shimazu S, Tsukada T, Sakurai A
Endocr J
. 2012 Aug;
59(12):1093-8.
PMID: 22878668
Germline MEN1 mutation analysis is a powerful tool for an early diagnosis of multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant familial cancer syndrome characterized by the parathyroid, pituitary...
10.
Nagamura Y, Yamazaki M, Shimazu S, Sano K, Tsukada T, Sakurai A
Endocr J
. 2012 Mar;
59(6):523-30.
PMID: 22447146
Heterozygous germline mutation of the tumor suppressor gene MEN1 is responsible for multiple endocrine neoplasia type 1 (MEN1), a familial cancer syndrome characterized by pituitary, parathyroid and enteropancreatic tumors. Various...